FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976535708> ?p ?o ?g. }

• W1976535708 endingPage "35" @default.
• W1976535708 startingPage "28" @default.
• W1976535708 abstract "The use of innocuous naturally occurring compounds to overcome drug resistance and cancer recalcitrance is now in the forefront of cancer research. Thymoquinone (TQ) is a bioactive constituent of the volatile oil derived from seeds of Nigella sativa Linn. TQ has shown promising anti-carcinogenic and anti-tumor activities through different mechanisms. However, the effect of TQ on cell signaling and survival pathways in resistant cancer cells has not been fully delineated. Here, we report that TQ greatly inhibits doxorubicin-resistant human breast cancer MCF-7/DOX cell proliferation. TQ treatment increased cellular levels of PTEN proteins, resulting in a substantial decrease of phosphorylated Akt, a known regulator of cell survival. The PTEN expression was accompanied with elevation of PTEN mRNA. TQ arrested MCF-7/DOX cells at G2/M phase and increased cellular levels of p53 and p21 proteins. Flow cytometric analysis and agarose gel electrophoresis revealed a significant increase in Sub-G1 cell population and appearance of DNA ladders following TQ treatment, indicating cellular apoptosis. TQ-induced apoptosis was associated with disrupted mitochondrial membrane potential and activation of caspases and PARP cleavage in MCF-7/DOX cells. Moreover, TQ treatment increased Bax/Bcl2 ratio via up-regulating Bax and down-regulating Bcl2 proteins. More importantly, PTEN silencing by target specific siRNA enabled the suppression of TQ-induced apoptosis resulting in increased cell survival. Our results reveal that up-regulation of the key upstream signaling factor, PTEN, in MCF-7/DOX cells inhibited Akt phosphorylation, which ultimately causes increase in their regulatory p53 levels affecting the induction of G2/M cell cycle arrest and apoptosis. Overall results provide mechanistic insights for understanding the molecular basis and utility of the anti-tumor activity of TQ." @default.
• W1976535708 created "2016-06-24" @default.
• W1976535708 creator A5002695125 @default.
• W1976535708 creator A5028382526 @default.
• W1976535708 creator A5049632099 @default.
• W1976535708 creator A5053181880 @default.
• W1976535708 creator A5064807660 @default.
• W1976535708 creator A5080151773 @default.
• W1976535708 creator A5081437624 @default.
• W1976535708 creator A5091610394 @default.
• W1976535708 date "2011-01-10" @default.
• W1976535708 modified "2023-10-04" @default.
• W1976535708 title "Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells" @default.
• W1976535708 cites W136889478 @default.
• W1976535708 cites W1549261396 @default.
• W1976535708 cites W1616649922 @default.
• W1976535708 cites W1650807611 @default.
• W1976535708 cites W1965424564 @default.
• W1976535708 cites W1968165842 @default.
• W1976535708 cites W1975375696 @default.
• W1976535708 cites W1976815300 @default.
• W1976535708 cites W1981373280 @default.
• W1976535708 cites W1984164274 @default.
• W1976535708 cites W1984418041 @default.
• W1976535708 cites W1991651255 @default.
• W1976535708 cites W1995726115 @default.
• W1976535708 cites W1996497433 @default.
• W1976535708 cites W1998836974 @default.
• W1976535708 cites W2004078164 @default.
• W1976535708 cites W2004868951 @default.
• W1976535708 cites W2006166664 @default.
• W1976535708 cites W2009295553 @default.
• W1976535708 cites W2016903551 @default.
• W1976535708 cites W2019467534 @default.
• W1976535708 cites W2020788984 @default.
• W1976535708 cites W2021647600 @default.
• W1976535708 cites W2022015635 @default.
• W1976535708 cites W2027811142 @default.
• W1976535708 cites W2029860792 @default.
• W1976535708 cites W2029962300 @default.
• W1976535708 cites W2031940639 @default.
• W1976535708 cites W2038616578 @default.
• W1976535708 cites W2051899483 @default.
• W1976535708 cites W2053265248 @default.
• W1976535708 cites W2057809866 @default.
• W1976535708 cites W2062540888 @default.
• W1976535708 cites W2087984101 @default.
• W1976535708 cites W2109424178 @default.
• W1976535708 cites W2112903366 @default.
• W1976535708 cites W2132279561 @default.
• W1976535708 cites W2135838271 @default.
• W1976535708 cites W2136353607 @default.
• W1976535708 cites W2142700129 @default.
• W1976535708 cites W2143811153 @default.
• W1976535708 cites W2143972162 @default.
• W1976535708 cites W2151837372 @default.
• W1976535708 cites W2154040159 @default.
• W1976535708 cites W2155290347 @default.
• W1976535708 cites W2164277862 @default.
• W1976535708 cites W2170825753 @default.
• W1976535708 cites W2398163779 @default.
• W1976535708 cites W2469151252 @default.
• W1976535708 cites W1540668106 @default.
• W1976535708 cites W2085333626 @default.
• W1976535708 doi "https://doi.org/10.1016/j.mrfmmm.2010.10.007" @default.
• W1976535708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3037029" @default.
• W1976535708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21040738" @default.
• W1976535708 hasPublicationYear "2011" @default.
• W1976535708 type Work @default.
• W1976535708 sameAs 1976535708 @default.
• W1976535708 citedByCount "169" @default.
• W1976535708 countsByYear W19765357082012 @default.
• W1976535708 countsByYear W19765357082013 @default.
• W1976535708 countsByYear W19765357082014 @default.
• W1976535708 countsByYear W19765357082015 @default.
• W1976535708 countsByYear W19765357082016 @default.
• W1976535708 countsByYear W19765357082017 @default.
• W1976535708 countsByYear W19765357082018 @default.
• W1976535708 countsByYear W19765357082019 @default.
• W1976535708 countsByYear W19765357082020 @default.
• W1976535708 countsByYear W19765357082021 @default.
• W1976535708 countsByYear W19765357082022 @default.
• W1976535708 countsByYear W19765357082023 @default.
• W1976535708 crossrefType "journal-article" @default.
• W1976535708 hasAuthorship W1976535708A5002695125 @default.
• W1976535708 hasAuthorship W1976535708A5028382526 @default.
• W1976535708 hasAuthorship W1976535708A5049632099 @default.
• W1976535708 hasAuthorship W1976535708A5053181880 @default.
• W1976535708 hasAuthorship W1976535708A5064807660 @default.
• W1976535708 hasAuthorship W1976535708A5080151773 @default.
• W1976535708 hasAuthorship W1976535708A5081437624 @default.
• W1976535708 hasAuthorship W1976535708A5091610394 @default.
• W1976535708 hasBestOaLocation W19765357081 @default.
• W1976535708 hasConcept C109541995 @default.
• W1976535708 hasConcept C121608353 @default.
• W1976535708 hasConcept C185592680 @default.
• W1976535708 hasConcept C190283241 @default.
• W1976535708 hasConcept C2776694085 @default.

• next